Alexander Hardy - 14 Mar 2025 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role: Chief Executive Officer, Director
Signature: /s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol: BMRN
Transactions as of: 14 Mar 2025
Net transactions value: -$203,668
Form type: 4
Filing time: 18 Mar 2025, 18:17:35 UTC
Previous filing: 03 Dec 2024
Next filing: 02 Dec 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BMRN	Common Stock	Tax liability	$203,668	-2,933	-2.2%	$69.44	131,223	14 Mar 2025	Direct
transaction	BMRN	Common Stock	Award	$0	+44,360	+34%	$0.000000	175,583	17 Mar 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BMRN	Stock Option (Right to Buy Common Stock)	Award	$0	+61,750		$0.000000	61,750	17 Mar 2025	Common Stock	61,750	$71.55	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units granted March 17, 2025. Price not applicable.
F2	Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter.